Clinical and genetic characterization of patientswith BCR::ABL1 and JAK2 V617F

被引：0
|
作者：
Dangelo, V. [1 ]
Schwaab, J. [1 ]
Luebke, J. [1 ]
Fabarius, A. [1 ]
Hagen, V. [2 ]
Horing, E. [3 ]
Dengler, J. [4 ]
Metzgeroth, G. [1 ]
Kreil, S. [1 ]
Hofmann, W. K. [1 ]
Saussele, S. [1 ]
Reiter, A. [1 ]
Naumann, N. [1 ]
机构：
[1] Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany
[2] St Johannes Hosp Dortmund, Klin Innere Med II, Dortmund, Germany
[3] Onkologikum Stuttgart, Stuttgart, Germany
[4] Onkolog Schwerpunktpraxis Heilbronn, Heilbronn, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V893
引用
收藏
页码：266 / 266
页数：1
相关论文
共 50 条
  • [41] JAK2 V617F mutation and the myeloproliferative disorders
    Vainchenker, William
    Casadevall, Nicole
    HEMATOLOGIE, 2006, 12 (01): : 3 - 7
  • [42] The JAK2 V617F mutation in the myeloproliferative disorders
    Sale, MA
    Awan, A
    Lucas, GS
    Yin, JAL
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 33 - 33
  • [43] The JAK2 V617F mutation in patients with anaemia
    S. E. Langabeer
    Irish Journal of Medical Science (1971 -), 2017, 186 : 349 - 350
  • [44] The JAK2 V617F mutation in essential thrombocythemia
    Cho, Young-Uk
    Chung, Hee-Jung
    Chi, Hyun-Sook
    Jang, Seoungsoo
    Park, Chan-Jeoung
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 103 - 103
  • [45] Causal role for JAK2 V617F in thrombosis
    Fleischman, Angela G.
    Tyner, Jeffrey W.
    BLOOD, 2013, 122 (23) : 3705 - 3706
  • [46] The JAK2 V617F mutation in breast cancer?
    Naeem, Mohammad Abdul
    BREAST JOURNAL, 2020, 26 (03): : 593 - 593
  • [47] THE JAK2 V617F MUTATION IN ISOLATED NEUTROPENIA
    Langabeer, Stephen E.
    EXCLI JOURNAL, 2018, 17 : 1 - 2
  • [48] The JAK2 V617F mutation in patients with anaemia
    Langabeer, S. E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (02) : 349 - 350
  • [49] The V617F JAK2 mutation and the myeloproliferative disorders
    Percy, MJ
    McMullin, MF
    HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) : 91 - 93
  • [50] Concomitant detection of BCR-ABL translocation and JAK2 V617F mutation in five patients with myeloproliferative neoplasm at diagnosis
    Cappetta, M.
    Perez, V.
    Zubillaga, M. N.
    Elizondo, V.
    Manrique, G.
    Prosper, I.
    Boschi, S.
    Bonomi, R.
    Pomoli, S.
    Diaz, L.
    Martinez, L.
    Uriarte, M. R.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 (01) : E4 - E5
12345